U.S. High Growth Tech and AI Stocks

Alkami Technology

Market Cap: US$2.9b

Provides cloud-based digital banking solutions in the United States.

AVITA Medical

Market Cap: US$139.1m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Lumentum Holdings

Market Cap: US$6.1b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

Ascendis Pharma

Market Cap: US$10.3b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$40.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

TG Therapeutics

Market Cap: US$5.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Ardelyx

Market Cap: US$863.7m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Super Micro Computer

Market Cap: US$26.5b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Mereo BioPharma Group

Market Cap: US$456.3m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Alvotech

Market Cap: US$2.7b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Blueprint Medicines

Market Cap: US$8.3b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Legend Biotech

Market Cap: US$6.4b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Palantir Technologies

Market Cap: US$330.3b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Soleno Therapeutics

Market Cap: US$4.0b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Similarweb

Market Cap: US$605.7m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

Verastem

Market Cap: US$285.2m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Roadzen

Market Cap: US$78.7m

Operates as an insurance technology company.

Vanda Pharmaceuticals

Market Cap: US$267.0m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

TruGolf Holdings

Market Cap: US$6.0m

Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.

Capricor Therapeutics

Market Cap: US$545.8m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

UroGen Pharma

Market Cap: US$685.6m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Travere Therapeutics

Market Cap: US$1.3b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Aldeyra Therapeutics

Market Cap: US$189.9m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Madrigal Pharmaceuticals

Market Cap: US$6.3b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

ARS Pharmaceuticals

Market Cap: US$1.6b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

OS Therapies

Market Cap: US$51.1m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

Achieve Life Sciences

Market Cap: US$108.9m

A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.

Abeona Therapeutics

Market Cap: US$306.9m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Tenaya Therapeutics

Market Cap: US$94.1m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

SpringWorks Therapeutics

Market Cap: US$3.5b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.

RenovoRx

Market Cap: US$50.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Zscaler

Market Cap: US$47.6b

Operates as a cloud security company worldwide.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Gorilla Technology Group

Market Cap: US$354.3m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

TeraWulf

Market Cap: US$1.5b

Operates as a digital asset technology company in the United States.

Workday

Market Cap: US$63.2b

Provides enterprise cloud applications in the United States and internationally.